We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+8.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$214M
AUM Growth
+$9.71M
Cap. Flow
-$616K
Cap. Flow %
-0.29%
Top 10 Hldgs %
6.68%
Holding
490
New
42
Increased
186
Reduced
165
Closed
36

Top Buys

Rank Stock Value
1
OCCI
OFS Credit Co
OCCI
+$2.05M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.92M
3
ECC
Eagle Point Credit Company
ECC
+$1.26M
4
APP icon
Applovin
APP
+$1.04M
5
CEG icon
Constellation Energy
CEG
+$1.01M

Top Sells

Rank Stock Value
1
OXLC
Oxford Lane Capital
OXLC
+$1.49M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.06M
3
GEN icon
Gen Digital
GEN
+$1.01M
4
ADBE icon
Adobe
ADBE
+$989K
5
STE icon
Steris
STE
+$907K

Sector Composition

Rank Sector Weight
1 Financials 28.16%
2 Healthcare 18.37%
3 Technology 14.33%
4 Industrials 8.16%
5 Consumer Discretionary 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
401
Bicycle Therapeutics
BCYC
$270M
$85.7K 0.04%
3,789
+64
+2% +$1.48K
SNDX icon
402
Syndax Pharmaceuticals
SNDX
$1.72B
$85.7K 0.04%
4,451
+78
+2% +$1.61K
SLN
403
Silence Therapeutics
SLN
$542M
$85K 0.04%
4,674
+83
+2% +$1.54K
TNGX icon
404
Tango Therapeutics
TNGX
$4.23B
$84.6K 0.04%
10,984
+194
+2% +$1.85K
IMNM icon
405
Immunome
IMNM
$2.65B
$84K 0.04%
5,743
+99
+2% +$1.41K
SYRE icon
406
Spyre Therapeutics
SYRE
$8.44B
$83.8K 0.04%
2,848
+51
+2% +$1.42K
CMPS
407
Compass Pathways
CMPS
$1.48B
$83.7K 0.04%
13,281
+237
+2% +$1.67K
KURA icon
408
Kura Oncology
KURA
$815M
$83.5K 0.04%
4,275
+78
+2% +$1.58K
RLAY icon
409
Relay Therapeutics
RLAY
$4.08B
$83.4K 0.04%
11,781
+212
+2% +$1.58K
RCUS icon
410
Arcus Biosciences
RCUS
$3.32B
$82.9K 0.04%
5,424
+99
+2% +$1.56K
IMTX icon
411
Immatics
IMTX
$1.21B
$81.2K 0.04%
7,115
+125
+2% +$1.48K
MRUS
412
DELISTED
Merus
MRUS
$79.7K 0.04%
1,595
+25
+2% +$1.3K
VERV
413
DELISTED
Verve Therapeutics
VERV
$79.6K 0.04%
16,455
+290
+2% +$1.68K
NAMS icon
414
NewAmsterdam Pharma
NAMS
$3.25B
$78.7K 0.04%
4,738
+81
+2% +$1.4K
GPCR icon
415
Structure Therapeutics
GPCR
$3.38B
$78.4K 0.04%
1,787
+34
+2% +$1.31K
SRRK icon
416
Scholar Rock
SRRK
$5.88B
$78.3K 0.04%
9,771
+171
+2% +$1.5K
IDYA icon
417
IDEAYA Biosciences
IDYA
$3.47B
$75K 0.04%
2,369
+44
+2% +$1.67K
RCKT icon
418
Rocket Pharmaceuticals
RCKT
$339M
$74.4K 0.03%
4,028
+68
+2% +$1.39K
RGNX icon
419
Regenxbio
RGNX
$623M
$73.9K 0.03%
7,043
+122
+2% +$1.49K
AUTL
420
Autolus Therapeutics
AUTL
$381M
$73.9K 0.03%
20,348
+364
+2% +$1.45K
ETNB
421
DELISTED
89bio
ETNB
$73.4K 0.03%
9,923
+179
+2% +$1.5K
NTLA icon
422
Intellia Therapeutics
NTLA
$1.52B
$73K 0.03%
3,550
+63
+2% +$1.45K
PRTA icon
423
Prothena Corp
PRTA
$447M
$72.2K 0.03%
4,315
+79
+2% +$1.7K
ABCL icon
424
AbCellera Biologics
ABCL
$1.67B
$72K 0.03%
27,678
+493
+2% +$1.37K
CGEM icon
425
Cullinan Oncology
CGEM
$1.04B
$70.8K 0.03%
4,228
+75
+2% +$1.33K
15 16
17
18 19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, Virtus ETF Advisers held 490 positions worth $214M, up 4.8% from $204M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Virtus ETF Advisers's Q3 2024 filing shows 42 new, 186 increased, 165 reduced and 36 closed positions. Its largest new stake was OFS Credit Co: 278,579 shares worth $2.06M. The largest sale was Oxford Lane Capital, an estimated $1.49M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

  • Virtus ETF Advisers's largest Q3 2024 buy was OFS Credit Co: 278,579 shares worth $2.06M.
  • Virtus ETF Advisers added most to Public Storage in Q3 2024, an estimated $927K increase.
  • Virtus ETF Advisers's biggest Q3 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.06M.
  • Virtus ETF Advisers fully exited Oxford Lane Capital in Q3 2024, selling an estimated $1.49M.
  • Virtus ETF Advisers's ten largest holdings make up 6.7% of its $214M portfolio in Q3 2024.
  • Virtus ETF Advisers opened 42 new positions and closed 36 in Q3 2024.
  • Virtus ETF Advisers's portfolio value rose 4.8% quarter-over-quarter to $214M.

Based on Virtus ETF Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.